Eisai Pharmaceutical Marketing Subsidiary in Singapore Launches Operations.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, July July: see month. 4, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Eisai Co., Ltd. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4523) has established a new pharmaceutical marketing subsidiary in Singapore, "Eisai (Singapore) Pte., Ltd." (ESN (Electronic Serial Number) A unique identification number built into a cellphone for security purposes. ), which has launched pharmaceutical import and marketing business. Previously, Eisai's pharmaceutical import and marketing business in Singapore was handled by Eisai Asia Regional Services Pte. Ltd. (EARS; Head office: Singapore; President: Hiroshi Kimura), but EARS has recently transferred this business to ESN. By launching operations with this new company, Eisai aims to strengthen its pharmaceutical business in Singapore and further contribute to patients' value in the region. EARS will renew its operation as a holding company assuming specific function of the seven local subsidiaries in the Asian region, including this newly established ESN in Singapore and existing six others in China, Thailand, Malaysia, the Philippines, Hong Kong Hong Kong (hŏng kŏng), Mandarin Xianggang, special administrative region of China, formerly a British crown colony (2005 est. pop. 6,899,000), land area 422 sq mi (1,092 sq km), adjacent to Guangdong prov. and India. Profile of Eisai (Singapore) Pte. Ltd. Capital: 300,000 Singapore dollars (approx. 22,000,000 yen) Location: Singapore President: Celine Ting Scope of Business: Import, marketing, and promotion of pharmaceuticals Capital Alliance: 100% subsidiary of EARS About Eisai Co., Ltd. Eisai Co., Ltd. (TSE: 4523)(OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : ESALY) is a research-based human health care company that discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. Eisai employs more than 8,000 people worldwide. For more information, please visit http://www.eisai.co.jp. Source: Eisai Co., Ltd. Contact: Eisai Co., Ltd. Corporate Communications Department +81-3-3817-5120 Copyright [c] 2006 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion